Log | Progress In Mind

Log Type	Authored on	Log Message	Log Node	Authored by
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Gäst
Newsletter clicked	Tue, 11/08/2022 - 13:18	Clicked https://korea.progress.im/ko/content/%EB%8C%80%EC%82%AC-%EC%9D%B4%EC%83%81-%EB%B0%8F-%EC%97%BC%EC%A6%9D%EC%9D%B4-%EA%B8%B0%EB%B6%84%EC%9E%A5%EC%95%A0%EC%97%90-%EB%AF%B8%EC%B9%98%EB%8A%94-%EC%98%81%ED%96%A5		Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Gäst
Newsletter clicked	Tue, 11/08/2022 - 13:18	Clicked https://korea.progress.im/ko/content/%EB%A7%9E%EC%B6%A4%ED%98%95-%EC%A3%BC%EC%9A%94%EC%9A%B0%EC%9A%B8%EC%9E%A5%EC%95%A0-%EC%B9%98%EB%A3%8C%EB%A5%BC-%ED%96%A5%ED%95%9C-%EB%85%B8%EB%A0%A5		Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Gäst
Newsletter clicked	Tue, 11/08/2022 - 13:18	Clicked https://korea.progress.im/ko/content/%EB%8C%80%EC%82%AC-%EC%9D%B4%EC%83%81-%EB%B0%8F-%EC%97%BC%EC%A6%9D%EC%9D%B4-%EA%B8%B0%EB%B6%84%EC%9E%A5%EC%95%A0%EC%97%90-%EB%AF%B8%EC%B9%98%EB%8A%94-%EC%98%81%ED%96%A5		Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Gäst
Newsletter clicked	Tue, 11/08/2022 - 13:18	Clicked https://korea.progress.im/ko/content/%EB%A7%9E%EC%B6%A4%ED%98%95-%EC%A3%BC%EC%9A%94%EC%9A%B0%EC%9A%B8%EC%9E%A5%EC%95%A0-%EC%B9%98%EB%A3%8C%EB%A5%BC-%ED%96%A5%ED%95%9C-%EB%85%B8%EB%A0%A5		Gäst
Newsletter clicked	Tue, 11/08/2022 - 13:18	Clicked https://korea.progress.im/ko/content/%EB%8C%80%EC%82%AC-%EC%9D%B4%EC%83%81-%EB%B0%8F-%EC%97%BC%EC%A6%9D%EC%9D%B4-%EA%B8%B0%EB%B6%84%EC%9E%A5%EC%95%A0%EC%97%90-%EB%AF%B8%EC%B9%98%EB%8A%94-%EC%98%81%ED%96%A5		Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Gäst

Log Type	Authored on	Log Message	Log Node	Authored by
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Gäst
Newsletter clicked	Tue, 11/08/2022 - 13:18	Clicked https://korea.progress.im/ko/content/%EB%8C%80%EC%82%AC-%EC%9D%B4%EC%83%81-%EB%B0%8F-%EC%97%BC%EC%A6%9D%EC%9D%B4-%EA%B8%B0%EB%B6%84%EC%9E%A5%EC%95%A0%EC%97%90-%EB%AF%B8%EC%B9%98%EB%8A%94-%EC%98%81%ED%96%A5		Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Gäst
Newsletter clicked	Tue, 11/08/2022 - 13:18	Clicked https://korea.progress.im/ko/content/%EB%A7%9E%EC%B6%A4%ED%98%95-%EC%A3%BC%EC%9A%94%EC%9A%B0%EC%9A%B8%EC%9E%A5%EC%95%A0-%EC%B9%98%EB%A3%8C%EB%A5%BC-%ED%96%A5%ED%95%9C-%EB%85%B8%EB%A0%A5		Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Gäst
Newsletter clicked	Tue, 11/08/2022 - 13:18	Clicked https://korea.progress.im/ko/content/%EB%8C%80%EC%82%AC-%EC%9D%B4%EC%83%81-%EB%B0%8F-%EC%97%BC%EC%A6%9D%EC%9D%B4-%EA%B8%B0%EB%B6%84%EC%9E%A5%EC%95%A0%EC%97%90-%EB%AF%B8%EC%B9%98%EB%8A%94-%EC%98%81%ED%96%A5		Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Gäst
Newsletter clicked	Tue, 11/08/2022 - 13:18	Clicked https://korea.progress.im/ko/content/%EB%A7%9E%EC%B6%A4%ED%98%95-%EC%A3%BC%EC%9A%94%EC%9A%B0%EC%9A%B8%EC%9E%A5%EC%95%A0-%EC%B9%98%EB%A3%8C%EB%A5%BC-%ED%96%A5%ED%95%9C-%EB%85%B8%EB%A0%A5		Gäst
Newsletter clicked	Tue, 11/08/2022 - 13:18	Clicked https://korea.progress.im/ko/content/%EB%8C%80%EC%82%AC-%EC%9D%B4%EC%83%81-%EB%B0%8F-%EC%97%BC%EC%A6%9D%EC%9D%B4-%EA%B8%B0%EB%B6%84%EC%9E%A5%EC%95%A0%EC%97%90-%EB%AF%B8%EC%B9%98%EB%8A%94-%EC%98%81%ED%96%A5		Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Gäst

Patrocinado por

Progress in Mind Brazil

INSCRIÇÃO NEWSLETTER